Congenital Portosystemic Shunts and Liver Hemangiomas in Children: Is There an Association?


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
01 08 2021
Historique:
received: 21 04 2020
accepted: 18 07 2020
pubmed: 21 8 2020
medline: 3 9 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

Liver hemangiomas are benign vascular tumors of infancy. They can have vascular shunting mostly arteriovenous and sometimes arterioportal or portosystemic, which improves as hemangiomas involute. In contrast, congenital portosystemic shunts are developmental vascular anomalies that may go undetected for years, with significant sequelae. We describe a child with a history of multiple cutaneous and liver hemangiomas in infancy and later diagnosis of congenital portosystemic shunt. Past experience of a similar patient and a current baby followed for liver hemangiomas with portosystemic shunts, is also shared. Literature is reviewed for known association. We suggest longer-term follow-up for babies with liver hemangiomas.

Identifiants

pubmed: 32815887
pii: 00043426-202108000-00014
doi: 10.1097/MPH.0000000000001918
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e766-e769

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

McLin VA, Franchi-Abella S, Debray D, et al. Congenital portosystemic shunts; current diagnosis and management. JPGN. 2019;68:615–622.
Papamichail M, Pizanias M, Heaton N. Congenital portosystemic venous shunt. Eur J Pediatr. 2018;177:285–294.
Wassef M, Blei F, Adams D, et al. On behalf of the ISSVA Board and Scientific Committee. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136:e203–e214.
Adams DM, Brandao LR, Peterman CM, et al. Vascular anomaly cases for the pediatric hematologist oncologists-an interdisciplinary review. Pediatr Blood Cancer. 2018;65:1–9.
Gallego C, Miralles M, Marin C, et al. Congenital hepatic shunts. Radiographics. 2004;24:755–772.
Kassarjian A, Zurakowski D, Dubois J, et al. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol. 2004;182:785–795.
Iacobas I, Phung TL, Adams DM, et al. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr. 2018;201:294–300.
Paley MR, Farrant P, Kane P, et al. Developmental intrahepatic shunts of childhood: radiologic features and management. Eur Radiol. 1997;7:1377–1382.
Hoover W, Ackerman V, Schamberger M, et al. The congenital porto-caval fistula: a unique presentation and novel intervention. Pediatr Pulmonol. 2008;43:196–199.
DiPaola F, Trout AT, Walther AE, et al. Congenital portosystemic shunts in children: associations, complications and outcomes. Dig Dis Sci. 2020;65:1239–1251.
Franchi-Abella S, Gonzales E, Ackerman O, et al. On behalf of the International Registry of Congenital Portosystemic Shunt members. Congenital portosystemic shunts: diagnosis and treatment. Abdom Radiol. 2018;43:2023–2036.
Bernard O, Franchi-Abella S, Branchereau S, et al. Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis. 2012;32:273–287.
Franchi-Abella S, Branchereau S, Lambert V, et al. Complications of congenital portosystemic shunts in children: therapeutic options and outcomes. J Pediatr Gastroenterol Nutr. 2010;51:322–330.
Ono H, Mawatari H, Mizoguchi N, et al. Clinical features and outcome of eight infants with intrahepatic portovenous shunts detected in neonatal screening for galactosemia. Acta Paediatr. 1998;87:631–634.
Eroglu Y, Donaldson J, Sorensen LG, et al. Improved neurocognitive function after radiologic closure of congenital portosystemic shunts. J Pediatr Gastroenterol Nutr. 2004;39:410–417.
Sakamoto S, Kasahara M, Shigeta T, et al. Living donor liver transplantation for multiple intrahepatic portosystemic shunts after involution of infantile hepatic hemangiomas. J Pediatr Surg. 2011;46:1288–1291.
Mreish S, Hamdan MA. Pre and postnatal diagnosis of congenital portosystemic shunt: impact of interventional therapy. Int J Pediatr Adolesc Med. Available at: https://doi.org/10.1016/j.ijpam.2019.02.009 .
doi: 10.1016/j.ijpam.2019.02.009
Hekimoglu K, Ustundag Y. Cavernous hemangioma with arterioportal and portosystemic shunts: precise diagnosis with dynamic multidetector computed tomography imaging. Abdom Imaging. 2010;35:328–331.
Tanaka A, Morimoto T, Yamamori T, et al. Atypical liver hemangioma with shunt: long term follow up. J Hepatobiliary Pancreat Surg. 2002;9:750–754.

Auteurs

Manjusha Kumar (M)

Indiana Hemophilia and Thrombosis Center.

Kannan Natarajan (K)

Interventional Radiology, St. Vincent Medical Group.

Rachel Dunn (R)

Peyton Manning Children's Hospital at St. Vincent - Pediatric Gastroenterology.

Aliyah Khan-Serrano (A)

Peyton Manning Children's Hospital at St. Vincent.

Charles Nakar (C)

Indiana Hemophilia and Thrombosis Center.

Angeli Rampersad (A)

Indiana Hemophilia and Thrombosis Center.

Anil Kumar (A)

St. Vincent Medical Group - Children's Heart Center, Indianapolis, IN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH